We are live on ! Find out more
STOK icon

Stoke Therapeutics
STOK

99 hedge funds and large institutions have $871M invested in Stoke Therapeutics in 2022 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 36 increasing their positions, 27 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 15

33% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 27

14.36% more ownership

Funds ownership: 96.33% → 110.69% (+14%)

5% more funds holding

Funds holding: 94 → 99 (+5)

2% more capital invested

Capital invested by funds: $855M → $871M (+$16M)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

Holders
99
Holders Change
+5
Holders Change %
+5.32%
% of All Funds
1.56%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
20
Increased
36
Reduced
27
Closed
15
Calls
$3.32M
Puts
–
Net Calls
+$3.32M
Net Calls Change
+$3.32M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$48.6M
2
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
+$26.8M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$23.8M
4
CAC
Cowen and Company
New York
+$22.5M
5
Millennium Management
Millennium Management
New York
+$5.57M

Top Sellers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
-$13.3M
2
GGHC
Gilder Gagnon Howe & Co
New York
-$10.2M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$5.61M
4
WWM
Westwood Wealth Management
California
-$5.28M
5
RG
Redmile Group
California
-$4.45M
Name Holding Trade Value Shares
Change 		Change in
Stake
CC
101
Casdin Capital
New York
– -$2.88M -120,000 Closed
VOYA Investment Management
102
VOYA Investment Management
Georgia
– -$1.98M -82,407 Closed
Jacobs Levy Equity Management
103
Jacobs Levy Equity Management
New Jersey
– -$539K -22,480 Closed
HF
104
HRT Financial
New York
– -$433K -18,057 Closed
Russell Investments Group
105
Russell Investments Group
United Kingdom
– -$319K -13,313 Closed
D.E. Shaw & Co
106
D.E. Shaw & Co
New York
– -$241K -10,065 Closed
ProShare Advisors
107
ProShare Advisors
Maryland
– -$224K -9,346 Closed
EAM
108
Erste Asset Management
Austria
– -$209K -9,200 Closed
Zurich Cantonal Bank
109
Zurich Cantonal Bank
Switzerland
– -$22K -901 Closed
Northwestern Mutual Wealth Management
110
Northwestern Mutual Wealth Management
Wisconsin
– -$18K -750 Closed
CFGS
111
Concourse Financial Group Securities
Alabama
– -$4K -200 Closed
HPC
112
HM Payson & Co
Maine
– -$2K -99 Closed
WWM
113
Westwood Wealth Management
California
– -$5.28M -95 Closed
Carson Wealth (CWM LLC)
114
Carson Wealth (CWM LLC)
Nebraska
– -$1K -55 Closed
1 2 3 4
5

STOK Hedge Fund Activity: Q1 2022 in Review

99 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Stoke Therapeutics (STOK) for Q1 2022, worth a combined $871M — up 1.9% from $855M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new STOK positions and 15 closed out — a net gain of 5 holders — while 36 added to existing stakes and 27 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $48.6M. The largest seller was Federated Hermes, cutting an estimated $13.3M.

  • 99 institutional investors held Stoke Therapeutics (STOK) as of Q1 2022, up from 94 in Q4 2021.
  • Funds reported $871M of Stoke Therapeutics stock for Q1 2022, up 1.9% quarter-over-quarter.
  • 20 funds opened new Stoke Therapeutics positions in Q1 2022 and 15 closed out, a net change of +5 holders.
  • The largest Stoke Therapeutics buyer in Q1 2022 was Morgan Stanley, an estimated $48.6M added.
  • The largest Stoke Therapeutics seller in Q1 2022 was Federated Hermes, an estimated $13.3M sold.

Based on aggregated 13F filings for Q1 2022.